September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Understanding Immune Mechanisms of Ocular Graft vs Host Disease
Author Affiliations & Notes
  • Victor L Perez
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Victor Perez, Allergan (C), EyeGate (C), Shire (F)
  • Footnotes
    Support  NEI 1 R01 EY024484-01, NEI 3 R01 EY024484-01S1 and Research Prevent Blindness
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Victor L Perez; Understanding Immune Mechanisms of Ocular Graft vs Host Disease. Invest. Ophthalmol. Vis. Sci. 2016;57(12):No Pagination Specified.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Ocular Graft vs. Host Disease is a common complication that occurs in patients that are recipient of a Hematopoietic Stem Cell Transplant (HSCT) for the treatment of many leukemic disorders. Unfortunately, these patients survive their malignancy, but their quality of life is poor secondary to the development of severe ocular surface inflammation, including dry eye. Ocular GVHD is an immunological attack orchestrated by donor T cells which expand in an “abnormal deregulated” immune environment of the recipient. Using a pre-clinical model of ocular GVHD our group has been able to characterize and start to understand the role of donor T cells in this disease. In this presentation we will discuss how immune deregulation at different levels of T cell priming and recruitment are responsible for the development of damage in the ocular compartment.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.